What are the consensus rankings for RX groups? How do many of them compare to top M&A groups on the street? As I'm going through the SA recruiting process right now, any clarity would be helpful.
| +413 | Change My Mind: Banks Shouldn’t Hire Foreigners at All | 111 | 2h |
| +208 | Article - UBS’ Investment Bank Keeps Losing Ground | 34 | 11h |
| +103 | Don’t work at UBS - UBS Sucks | 13 | 1h |
| +80 | An Exhaustive Guide: How to Solve Every Single Accretion/Dilution Question | 7 | 4h |
| +52 | When to Leave Office as Intern | 6 | 32m |
| +43 | Best IB Group Overall? | 25 | 1d |
| +34 | Would you rather be a Touse Squid or a Bouse Mogger in IB | 2 | 2d |
| +31 | What do you say to ppl who don’t know EVR/LAZ/CVP/PJT | 22 | 1d |
| +31 | STEM student lost in London IB recruiting | 17 | 21h |
| +20 | Still recruiting SA'27 | 13 | 20h |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
From a deal flow perspective relative to headcount:
1A. EVR, PJT
1B. HL
1C. MOE, LAZ, PWP, CVP, GUGG, DUC
From an exits perspective besides gugg and Ducera they should all be relatively comparable. I don’t know people well enough at gugg and Ducera so someone else can comment. I know analysts from all these places get interviews at places like Apollo, Blackstone, KKR, etc. with relative ease. At this point it’s really more on the candidate.
Rx and m&a isn’t sn apples to apples comparison. It’s more of a apples vs pear. If you think there’s a chance you’ll consider growth oriented roles (corp dev, GE, VC) then you should do M&A. If you want to do credit, distressed, more legal oriented stuff then rx would be great
Think it should be more:
tier 1: PJT
tier 2: EVR, HL in that order
PJT has separated from the rest of the pack over the past ~18 months.
Bro what are you smoking? PJT and evercore are literally neck and neck. I don’t even work at Evercore but Look on reorg they and pjt take like 80% of the most topical deals in rx.
HL isn’t the same as those two. There have been a few times HL was once the advisor and later on Evercore/pjt/ended up being the new FA for the group they represented… that’s pretty fucking embarrassing lol
When’s the last time Ducera was on a relevant debtor side
Diebold, Yellow
What are the exits when you enter RX as an MBA associate? Do you get buyside roles at HF or are you considered a career banker? I've heard mixed opinions on it.
unfortunately the career paths might be restricted to CFO of a midwestern trucking company, hoping thats not true though. I dont know very many post MBA bankers that trasitioned to a good buyside
HL average mandate quality isn’t comparable to PJT/EVR/CVP/PWP…go down market and do some very small deals
The reality is the actual EBs have much better platforms / industry teams than HL and aren’t as willing to bottom feed for deals
idk why people hating lol. You're not wrong.
London rankings?
1) PJT
2) HL
Huge gap
3) Everyone else
What happened to the LAZ team? I thought they were good historically
https://www.wsj.com/articles/lazard-fires-top-restructuring-banker-accu…
Among other things
Where do Piper / Baird / Ray J / Miller Buckfire fit in?
Miller Buckfire was good 10 years ago, the others have non existent restructuring practices.
Miller Buckfire was good 10 years ago, the others have non existent restructuring practices.
Miller Buckfire was good 10 years ago, the others have non existent restructuring practices.
These are all good firms with strengths and weaknesses. PJT probably the premier name in the space
If you are asking from an analyst perspective who wants best exit opps, I think you put PJT EVR HL and Moelis at the top of the list
Anyone ever see movement from law to Rx? Have a family friend who's a 1st yr. associate in biglaw (V30-50) who wants to make the move, but doesnt do Rx law (does PE/M&A). Not knowledgeable on the Rx space so just curious if you guys see that move often
Eum atque quia aliquid ratione sint. Fuga maxime delectus eum alias dolorem. Necessitatibus delectus aliquam rem rerum inventore.
Pariatur possimus totam quia qui exercitationem aut ut. Aut sint nulla non molestiae rerum vel.
Veritatis aut quos odio voluptatem eum vel. Sunt at sed et harum iusto dolor. Perspiciatis at minima nobis eum sequi quis. Deserunt iure et quas suscipit commodi quas et. Consequatur blanditiis numquam aut. Quia libero perferendis aspernatur quaerat dolorem. Dolores nam dolorem voluptate ut aperiam repellendus iusto.
Earum quia cumque dolorem voluptas. Magni eaque doloribus similique ad non aut. Qui eum et mollitia fuga aut assumenda molestiae. Ab repellendus et fugiat voluptatem quos. Provident ut occaecati voluptas laudantium id esse. Maxime blanditiis et placeat nostrum dolor beatae numquam. Vel repellendus adipisci deserunt sit dolores sunt.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Unde eos harum qui natus autem. Quisquam omnis exercitationem est perferendis. Aspernatur laboriosam pariatur qui. Consequatur autem qui enim et.
Nihil ea fugiat illum asperiores. Dignissimos dolorem magni quis reprehenderit odio nihil iusto. Id explicabo unde at voluptas dolorem vel. Praesentium similique earum deleniti dolore amet est iusto vitae. Sed harum veritatis ipsa dicta. Ut architecto error debitis et.
Ab consequatur illum enim consequatur quibusdam dolorum in consequatur. Labore consectetur delectus id ea officiis.